Qiagen Rises as Profit Forecast Tops EstimatesSimeon Bennett
Qiagen NV, a maker of medical diagnostic equipment, increased to its highest value in two-and-a-half years after forecasting 2013 profit that exceeded analysts’ estimates.
Qiagen climbed 6.8 percent to 15.66 euros in Frankfurt, the highest closing price since July 15, 2010, giving the company a market value of 3.6 billion euros ($4.9 billion).
Adjusted earnings this year will rise to about $1.16 to $1.18 a share, Qiagen said in a statement late yesterday. Analysts had predicted profit of $1.12, the average of 31 estimates compiled by Bloomberg.
Qiagen is based in Venlo, the Netherlands, with management offices in Hilden, Germany.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.